Comparison of Zotarolimus-Eluting and Sirolimus-Eluting Stents in Patients With Native Coronary Artery Disease: A Randomized Controlled Trial
J Am Coll Cardiol Kandzari et al.
48: 2440
ENDEAVOR III Trial Study Sites and Principal Investigators
ENDEAVOR III Trial Study Sites and Principal Investigators
Files in this Data Supplement:
|